Project Grant HT9425261E091
Award Date 6/1/26
Completion Date 5/31/28
Dollars Obligated $840K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- Federal Grant Award Summary The Washington University received a $155,500 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025, through September 30, 2027. The research project investigates LAT1 (L-type amino acid transporter 1) as a therapeutic and diagnostic marker in malignant peripheral nerve sheath tumors (MPNSTs). This two-year initiative supports hypothesis-driven biomedical research...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- The Defense Health Agency awarded a $929,948 Project Grant to The Washington University in St. Louis, Missouri to support the research project "TARGETING TDP-43 MITOCHONDRIAL MISLOCALIZATION IN ALS". This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. The research project will investigate mitochondrial...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $840,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded April 1, 2026, with a completion date of March 31, 2028. The award supports research efforts titled "Repurposing Approved Drugs as First-in-Class Disruptors of the P38/MK2 Complex to Suppress Neuroinflammation in ALS," with research activities...
- The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...
- Federal Grant Award Summary The Washington University was awarded $500,000 in Project Grant funding from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2027. The award supports research titled "Harnessing Single-Cell T Cell-Receptor Sequencing to Accelerate Diagnosis in Inflammatory Arthritis," to be conducted at the university's University City, Missouri campus. This research project...
- Federal Project Grant Award Summary The Washington University received a $210,292 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award supports research into "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma," conducted at the university's Office of Sponsored Research Services in University City, Missouri....
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $256,208 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The grant supports research on deuterium metabolic imaging as a noninvasive diagnostic tool to measure metabolic reprogramming in glioblastoma, a severe form of brain cancer. This research aims to develop...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $447,625 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025, through May 31, 2028. This award supports research on refractive surgery for autism spectrum disorder (ASD), leveraging the university's established capabilities in advanced biomedical research and clinical investigation. The...
- This $437,544 Project Grant award was made on September 30, 2023 by the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program. The grant supports research at The Washington University in St. Louis, Missouri to study the phosphorylation tau profile of veterans with traumatic brain injury (TBI). The 3-year research project aims to improve understanding of neurological conditions affecting military service members and veterans. As a prominent private research...